Related Experiment Video
Updated: Aug 8, 2026
Optimized PCR-based Detection of Mycoplasma
Published on: June 20, 2011
[Serologic early diagnosis of pneumonia caused by Mycoplasma pneumoniae]
M Schmidt-Ioanas1, M Bender, A Roth
1Pneumologische Abteilung I, Helios Klinikum Emil von Behring, Lungenklinik Heckeshorn. imalina@yahoo.com
Background And Objective:
The definitive diagnosis of M. pneumoniae is encumbered by the lack of a rapid and cost-effective test of detection. The study aimed to determine if a single serological test within the first days of hospital admission may be relevant for the diagnosis of community-acquired pneumonia (CAP) caused by M. pneumoniae.
Patients And Methods:
Patients with suspected of CAP were investigated for microbiological diagnosis based on respiratory samples (bronchoalveolar lavage, bronchial aspirate, sputum, throat rinse), blood culture and serology for detection of atypical organisms and viruses. Patients with M. pneumoniae antibody titers > or = 1:160 were further investigated by polymerase chain reaction (PCR) for detection of M. pneumoniae in respiratory samples. The group of CAP by M. pneumoniae (MP-CAP) included patients with serum titers > 1:160 of M. pneumoniae antibodies (based on a single antibody determination at admission). The control group (non-MP-CAP group) included patients with CAP by pathogens other than M. pneumoniae or with no definitive bacteriological diagnostic.
Results:
Twenty adults with MP-CAP and 20 controls with non-MP-CAP were included. PCR was positive in 18/20 (90 %) of the MP-CAP group and negative in the 9/9 (100 %) investigated patients of the non-MP-CAP group. The duration of symptoms prior to hospital admission was rather long in both groups (mean 13.2 days in the MP-CAP group and 12,7 days in the non-MP-CAP group). The MP-CAP group was significantly younger (p = 0.002), had subsequently less associated comorbidities (p < 0.001) and less purulent sputum (p = 0.003) than the non-MP-CAP group.
Conclusion:
Single serology at admission with M. pneumoniae antibody titers > 1:160 may be useful for the diagnosis of CAP caused by M. pneumoniae in hospitalized patients with a long duration of symptoms (> 12 days).
Insights
A single serological test for Mycoplasma pneumoniae (M. pneumoniae) antibodies upon hospital admission can aid in diagnosing community-acquired pneumonia (CAP). This rapid test is particularly useful for patients with prolonged symptoms exceeding 12 days.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Clinical Diagnostics
Context:
- Diagnosing Mycoplasma pneumoniae (M. pneumoniae) community-acquired pneumonia (CAP) is challenging due to the absence of rapid, cost-effective detection methods.
- Early identification of M. pneumoniae is crucial for appropriate patient management and public health.
- Current diagnostic approaches often involve lengthy microbiological investigations.
Purpose:
- To evaluate the utility of a single serological test for M. pneumoniae antibodies at hospital admission for diagnosing M. pneumoniae CAP.
- To determine if elevated M. pneumoniae antibody titers (> or = 1:160) correlate with M. pneumoniae infection in hospitalized patients.
- To compare clinical characteristics of patients with M. pneumoniae CAP versus other CAP etiologies.
Summary:
- A study included 20 adults with M. pneumoniae CAP (MP-CAP) and 20 controls with non-M. pneumoniae CAP.
- M. pneumoniae was confirmed in 90% of MP-CAP patients via PCR after initial serology indicated titers > or = 1:160.
- MP-CAP patients presented with younger age, fewer comorbidities, and less purulent sputum compared to controls, often with symptoms exceeding 12 days.
Impact:
- Single serological testing at admission shows promise as a valuable tool for early M. pneumoniae CAP diagnosis.
- This approach can expedite the identification of M. pneumoniae infections, especially in patients with prolonged symptom duration.
- Findings support the integration of serological screening into initial CAP diagnostic protocols for specific patient groups.
Related Concept Videos
01:30Pneumonia III: Complications and Assessment
01:14Atypical Pneumonia